Researchers test flu shot for vulnerable transplant patients
NCT ID NCT01086904
Summary
This study tested the safety and effectiveness of an H1N1 flu vaccine in people who have received a kidney transplant. The 122 participants were all taking strong medications to prevent organ rejection, which can weaken the immune system. Researchers measured the body's immune response to the vaccine and monitored for any side effects over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOSUPPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre hospitalier Lyon Sud, service de néphrologie transplantation
Pierre-Bénite, Lyon, 69495, France
-
Hôpital E. Herriot , Service de néphrologie, transplantation et immunologie clinique
Lyon, 69437, France
-
Service d'urologie, GH Pitié Salpêtrière
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.